Skip to main content
Leukemia drug clofarabine available as generic in US
5/19/2017

Fresenius Kabi has begun marketing a generic version of Genzyme's Clolar, or clofarabine, in the US. The single-dose vial is indicated for the treatment of relapsed or refractory acute lymphoblastic leukemia in patients ages 1 to 21 years.

Full Story: